Navigation Links
Pivotal national trial uses newest interventional radiology treatment to bust blood clots in legs
Date:9/15/2008

FAIRFAX, Va.ATTRACTthe first major national trial of a catheter-based treatment for deep vein thrombosiswill evaluate the use of clot-dissolving drugs in combination with clot removal devices to prevent post-thrombotic syndrome in patients with DVT (the formation of a blood clot in a leg vein). PTS, a common irreversible complication of DVT, causes permanent damage to the veins, resulting in debilitating chronic leg pain, swelling, fatigue and/or skin ulcers. About 25�� percent of DVT patients develop PTS when treated with blood thinners alone. While early treatment with blood thinners is important to prevent a life-threatening pulmonary embolism, blood thinners alone do not dissolve the existing clot, which remains in the leg. Preliminary studies have shown that interventional clot-busting treatments canunlike standard DVT therapyremove clots and have strong potential to prevent PTS. The outcomes of this pivotal multicenter trialto be funded at more than $10 million by the National Institutes of Health's National Heart, Lung and Blood Institute (NHLBI)are likely to change the way DVT is treated in the United States.

"The ATTRACT trial could fundamentally shift the 50-year-old DVT treatment paradigm to one that includes interventional clot removal as an essential element of standard DVT care," said interventional radiologist Suresh Vedantham, M.D., who will lead the trial. "By funding this study, the NHLBI has clearly recognized the strong potential of interventional radiology clot removal treatments for DVT to improve public health," added the associate professor at the Washington University School of Medicine's Mallinckrodt Institute of Radiology in St. Louis, Mo.

ATTRACT (Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis) is a multicenter, randomized trial "that will definitively determine if the newest clot-busting treatment (pharmacomechanical catheter-directed thrombolysis or PCDT) pr
'/>"/>

Contact: Maryann Verrillo
mverrillo@SIRweb.org
703-460-5572
Society of Interventional Radiology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Wolves find happy hunting grounds in Yellowstone National Park
2. BIO-key(R) International to Showcase Deployed Biometric Security Applications at 2007 Biometric Technology Expo
3. ESMO International Symposium on Immunology
4. Story tips from the US Department of Energys Oak Ridge National Laboratory, September 2007
5. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
6. Director of National Intelligence to Speak at Conference
7. Singapore National Science and Technology Awards
8. Conservation International and Toyota partner to protect Philippines rain forests
9. International team shows mercury concentrations in fish respond quickly to increased deposition
10. International team shows mercury concentrations in fish respond quickly to increased deposition
11. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...nction of plant and animal species can be likened ... a cabinet full of potential medicines into the tr...d,s burgers. , But the decline of species and th...ew research now suggests it may also put you at gr...abitat destruction and biodiversity loss,"driven b...
(Date:12/3/2009)...ERQUE, N.M. Most scientists believe that staph in...ignal each other to emit toxins. The signaling pro...a must be present to start the process. , But th...the very first stage of staph infection, when bact...curs in a single cell and that this individual pro...
(Date:12/3/2009)...wellers must be included in the design of the upco... humanitarian crisis, according to a scientist at ...ture , Dr Simon Lewis argues that at least 50% of ...gen, known as REDD (Reducing Emissions from Defore... dwellers directly, and their property rights assu...
Breaking Biology News(10 mins):Species down, disease up 2Species down, disease up 3Species down, disease up 4Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Kidney Community Launches Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients in Iowa 48347 1Kidney Community Launches Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients in Iowa 48347 2Kidney Community Launches Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients in Iowa 48347 3Study finds colorectal cancer rates increasing worldwide 8769 1Study finds colorectal cancer rates increasing worldwide 8769 2Pharmacy Organizations Brief Congress on Medication Therapy Management 48343 1Pharmacy Organizations Brief Congress on Medication Therapy Management 48343 2Pharmacy Organizations Brief Congress on Medication Therapy Management 48343 3
...udy has shown promising results in fighting a seve...ghout the body. , Advances in genetic knowledge h...cent years. We now know which genes are linked to ...y few cures and treatments have developed as a res...searchers at Cardiff University suggests that a ch...
...phia, PA, 10 January 2008 A Web site is a better ...me or printed pamphlet, according to a study of lo...the Journal of Nutrition Education and Behavior ( ....D., of Michigan State University, East Lansing, t...th nutrition information in different formats. On...
...2008Zigzagging some 60,000 kilometers across ocean... pivotal role in many workings of the planet, from...e interior, and the chemistry of rock, water and a...s discovered the existence of vast plumbing system...rheat it, then spit it back out from seafloor vent...
Other Biology News:Genetic breakthrough offers promise in tackling kidney tumors 2For nutrition info, moms like the Web best 2Quakes under Pacific floor reveal unexpected circulatory system 2Quakes under Pacific floor reveal unexpected circulatory system 3
(Date:12/3/2009)... NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr...at Shenzhen Beike Biotechnology Co. Ltd.,( http://...High-Risk Diabetic,Foot Care in New Delhi, India, ...ell research and regenerative medicine company. ,...odiatry Association (IPA), aimed,to help podiatris...
(Date:12/2/2009)... YORK, Dec. 2 Reportlinker.com ann...ble in its catalogue: ,, Carbondioxide Incubat...ww.reportlinker.com/p0164368/Carbondioxide-Incubat...ubators are the most critical equipment used in mi...applications for providing a controlled environmen...
(Date:12/2/2009)... Calif., Dec. 2 Peregrin...orted completion of patient enrollment in a dose c... patients with relapsed glioblastoma multiforme (G...s a targeted monoclonal antibody linked to a radio...nt for GBM. Cotara specifically targets cells at ...
(Date:12/2/2009)...RIDGE, Mass., Dec. 2 TechConnect W...chnology development and product integration in cl... December 11th deadline for technology abstracts a...ear, TechConnect World, in association with the Na...e Clean Technology and Sustainable Industries Orga...
Breaking Biology Technology:Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3
...Meeting of Shareholders to Vote on Proposed Merger...ember 20, 2007 -- -- McNeil Trust to Vo... Arrow International,Inc. (Nasdaq: ARRO ) today ...d Exchange Commission and mailed to Arrow sharehol... the Company,s 2007 Annual Meeting of,Shareholders...
... Md., Aug. 24 Stem cell company,Neuralstem, Inc. ...s shares,have been accepted for listing on the Ame... CUR. Neuralstem shares are expected to begin trad...ex is the next logical step for Neuralstem. It is ...s the company has made in,each and every phase of ...
... Aug. 23 eBioscience Corporation announced,the ap...science, effective,immediately. Dr. Nelson comes t... was Vice President, Global Corporate Development....Lai, eBioscience,s,founder, will remain as Preside...in eBioscience,s Board of Directors. Dr. Nelson c...
Other Biology Technology:Arrow International Files and Mails Definitive Proxy Materials 2Arrow International Files and Mails Definitive Proxy Materials 3Arrow International Files and Mails Definitive Proxy Materials 4Neuralstem Shares Accepted for Trading on Amex(R) 2Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc. 2
...77 amino acid polypeptide sequence corresponding t... by activation of a recombinant soluble proform of...C ACTIVITY:The specific activity of MT1-MMP cataly...ty that hydrolyzes 1 mol peptide (7-methoxycoumari...
..., lightweight, high current power supply capable o...is an excellent choice for PAGE, SDS-PAGE and DNA ...pes of electroblotting applications.A dual functio...run and wil automatically accrue elapsed time when...
Anti-Interferon-beta (IFNb) Monoclonal Antibody, Unconjugated from CHEMICON
...apor Trap Models RVT100, RVT400, RVT405DDA, RVT410... UVS400A and UVS800DDA., A non-corrosive, odorles...or use for temperatures ranging from -105 to +260 ...ability and does not evaporate. Far superior to dr...
Biology Products: